AR420626
From Wikipedia, the free encyclopedia
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H18Cl2N2O3 |
| Molar mass | 417.29 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
AR420626 is an experimental drug which acts as a reasonably potent and highly selective agonist for the free fatty acid receptor FFAR3 (GPR41).[1][2] It has been used to research the role of FFAR3 in various disease processes such as diabetes,[3] asthma,[4] eczema[4] and some forms of cancer,[5] as well as regulation of gastrointestinal hormone release.[6]